Evidence map›Paper›PMID 40142543›Full record

ReviewMicroorganisms2025

Ashish Bhargava, Katherine Klamer, Mamta Sharma, Daniel Ortiz, Louis Saravolatz

Abstract readReview
In one paragraph

Review in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Proteome Remodelling inJournal of fungi (Basel, Switzerland) · 2026
    Article
  4. Clinical and Microbiological Characteristics of EarlyAntibiotics (Basel, Switzerland) · 2026
    Article
  5. Study Clinical Characteristics and Outcomes ofJournal of clinical medicine · 2026
    Article
  6. Review
  7. Clinical Outcomes of Micafungin and Anidulafungin inJournal of fungi (Basel, Switzerland) · 2026
    Article
  8. A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  9. Article
  10. Article
  11. Recent Outbreaks, Resistance Trends, and Control Measures inJournal of fungi (Basel, Switzerland) · 2026
    Review
  12. Observational
  13. JAC-antimicrobial resistance · 2026
    Article
  14. ManagingInfection prevention in practice · 2026
    Article
  15. Diabetes and Immunosuppression Drive Distinct Patterns ofbioRxiv : the preprint server for biology · 2026
    Article
  16. Article
  17. Article
  18. Genomic landscape ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  19. Efficacy of continuous UV-CInfection control and hospital epidemiology · 2026
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ashish BhargavaThomas Mackey Center of Infectious Diseases, Henry Ford Health-St. John Hospital, Detroit, MI 48236, USA.ORCID 0000-0001-6326-0908
Katherine KlamerThomas Mackey Center of Infectious Diseases, Henry Ford Health-St. John Hospital, Detroit, MI 48236, USA.
Mamta SharmaThomas Mackey Center of Infectious Diseases, Henry Ford Health-St. John Hospital, Detroit, MI 48236, USA.
Daniel OrtizLabCorp-Health Systems Operating Division, Troy, MI 48083, USA.ORCID 0000-0001-6100-1822
Louis SaravolatzThomas Mackey Center of Infectious Diseases, Henry Ford Health-St. John Hospital, Detroit, MI 48236, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antifungal resistanceCandida aurisnosocomial transmissionpathogenic fungi

Identifiers

PMID40142543
PMCPMC11946832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.